The most common error related to the use of metered dose inhalers was the failure to attach the inhaler to a spacer. SAN ANTONIO — In the United States, two-thirds ...

From asthma to COPD, inhalers are central to keeping symptoms under control—but choosing one involves more than convenience. Updated guidelines and research now factor in patient-specific health data, ...

Please provide your email address to receive an email when new articles are posted on . “Many health care systems are discussing a transition to dry-powder inhalers that have a lower carbon footprint ...

Delivery of asthma medication with pressurized metered-dose inhalers is economical, effective, and convenient. This method of delivery is a critical part of the medical management program for most ...

PORTLAND, Ore., Nov. 26, 2025 /PRNewswire/ -- Summary: Metered Dose Inhalers (MDIs) are widely used in the treatment and management of respiratory conditions such as asthma and chronic obstructive ...

Please provide your email address to receive an email when new articles are posted on . The majority of patients demonstrated improper usage of epinephrine autoinjectors and metered-dose inhalers, ...

A total of 425 patients were included in both the modified intention-to-treat and safety analyses. ATLANTA, GA—Findings of a Phase 3 study (NCT02513160) presented at the 2017 AAAAI Annual Meeting ...

A recent study found that teach-to-goal methods are more effective than brief interventions in metered-dose inhaler education for patients with chronic obstructive pulmonary disease (COPD) and asthma, ...

The situation is an ironic one. While climate change is worsening respiratory illnesses — by increasing extreme heat, spreading smoke from wildfires, and lowering air quality — one of the most common ...

Dr. Miguel Divo, a lung specialist at Brigham and Women’s Hospital, sits in an exam room, across from one of his patients with asthma. Joel Rubinstein, a retired psychiatrist, is about to get a ...

ATLANTA, Georgia — Patients with chronic obstructive pulmonary disease (COPD) experience few adverse events and discontinuations when treated with an ipratropium plus albuterol inhalation spray (CVT-R ...